Cette page n'est pas disponible actuellement dans votre langue. Vous pouvez en afficher une traduction automatique avec l'outil Google Translate. Cependant nous déclinons toute responsabilité quant à ce service et nous ne contrôlons pas les résultats de la traduction.
Pour en savoir plus à ce sujet, contactez-nous.
The Guangdong Medical University in China develops a method for non-invasive prostate cancer screening using Renishaw's inVia™ confocal Raman microscope
14th December 2016
New research at the Guangdong Medical University suggests a laser-based approach could be the latest breakthrough in prostate cancer detection. The proposed non-invasive blood test uses a combination of two techniques: surface-enhanced Raman scattering (SERS) and a new mathematical analysis technique called support vector machine (SVM). Together, these techniques produce an accuracy up to 98.1 percent; a far cry from the relative guesswork of prostate-specific antigen (PSA) tests. Professor Shaoxin Li, the study leader at the University commented, “Compared to traditional screening methods, this method has the advantage of being non-invasive, highly sensitive, and very simple for prostate cancer screening.” 1
Professor Li continues, “Cancer is one of the diseases that seriously threatens human life. It is important to improve the survival of patients by early diagnosis and treatment. Currently, there are many diagnostic methods available—including B-mode ultrasound, CT scan, biopsy and histopathology assessment—but these techniques have various limitations. For example, B-mode ultrasound only discerns the solid tumour and is therefore not applicable to patients in the early stages of cancer. Biopsy and histopathology assessment are the gold standard of cancer examination but they are invasive and impractical for high-risk patients with multiple suspicious lesions. We hope to develop a rapid, non-destructive, optical diagnosis method to solve these problems.
“Advanced Raman spectroscopy has provided the possibility to meet our goals and after much evaluation of alternative Raman systems, including portable Raman instruments, we chose the Renishaw inVia confocal Raman microscope. We selected the inVia because it offers continuous scanning from 50 to 4000 wavenumbers [using SynchroScan, Renishaw's patented method of acquiring wide-range spectra] and its high sensitivity makes it suitable for biological tissue measurement. It is also highly automated with software that is powerful and easy to use.”
To illustrate the sensitivity in use, Professor Li shows an example comparing SERS spectra of serum samples with silver colloids. The differences in the spectra reveal the enormous potential to diagnose cancer using the serum SERS technique.
The results show normalized mean SERS spectra of prostate cancer and normal serum sample. (a) cancer, (b) normal, (c) difference in spectra (cancer-normal). The shaded area represents the standard deviations.
Please visit www.renishaw.com/bio for further details on how Renishaw's inVia confocal Raman microscope is being used in the life sciences.
Reference
1 Non-invasive prostate cancer screening based on serum surface-enhanced Raman spectroscopy and support vector machine; Shaoxin Li et al; Appl. Phys. Lett. 105, 091104 (2014); http://dx.doi.org/10.1063/1.4892667
Downloads
For further images, videos, company biographies or information on Renishaw and its products, visit our Media Hub.